For the quarter ending 2026-03-31, BHIC made $750,946 in revenue. -$229,907 in net income. Net profit margin of -30.62%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 750,946 | 1,572,757 | 1,131,427 | 1,757,463 |
| Cost of goods sold | 265,350 | 1,000,894 | 433,196 | 682,985 |
| Gross profit | 485,596 | 571,863 | 698,231 | 1,074,478 |
| General and administrative expenses | 625,809 | 656,204 | 576,656 | 540,074 |
| Consulting fees | 89,694 | 72,328 | 130,357 | 76,700 |
| Total operating expenses | 715,503 | 728,532 | 707,013 | 616,774 |
| Income (gain) from operations | -229,907 | -156,669 | -8,782 | 457,704 |
| Income tax expense | - | 76,961 | - | - |
| Net income (gain) | -229,907 | -233,630 | -8,782 | 457,704 |
| Basic EPS | -0.02 | -0.021 | 0 | 0.01 |
| Diluted EPS | -0.02 | -0.02 | 0 | 0.01 |
| Basic Average Shares | 11,376,802 | 10,979,058* | 10,979,055 | 43,916,221 |
| Diluted Average Shares | 11,376,802 | 11,399,058* | 10,979,055 | 44,336,221 |
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)